Reversal of Micrographia in Parkinson's Disease by Application of Picotesla Range Magnetic Fields

References

• Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anton-Tay F., Diaz J. L., Fernandez-Guardiola A. On the effects of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid-brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Burton S., Daya S., Potgieter B. Melatonin modulates apomorphine-induced rotational behaviour. Experientia 1991; 47: 466–469
   PubMedGoogle Scholar
• Cardinali D. P., Vacas M. I., Boyer E. E. Specific binding of melatonin in bovine brain. Endocrinology 1979; 105: 437–441
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movement induced by L-dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Dray A. Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. Journal of Physiology (Paris) 1981; 77: 393–403
   PubMedGoogle Scholar
• Eliasberg W. G. Pen, paper and parkinsonism. Geriatrics 1959; 14: 705–708
   PubMedGoogle Scholar
• Gaffori O., Van Ree J. M. Serotonin and antidepressant drugs antagonize melatonin-induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985; 24: 237–244
   PubMed Web of Science ®Google Scholar
• Knopp W. Explorations in the assessment and meaning of the subclinical extrapyramidal effect of neuroleptic drugs. Pharmakopsychiatrie 1968; 1: 54–61
   Google Scholar
• Koller W. C. Classification of parkinsonism. Handbook of parkinson's disease, W. C. Koller. Marcel Dekker, New York 1987; 51–80
   Google Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neuroscience Letters 1980; 19: 237–242
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• LeWitt P. Micrographia as a focal sign of neurological disease. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 1152–1153
   PubMed Web of Science ®Google Scholar
• Neff N. H., Barett R. E., Costa E. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia 1969; 25: 1140–1141
   PubMedGoogle Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1979; 55: 219–220
   PubMed Web of Science ®Google Scholar
• Parkinson J. An essay on the shaking palsy. Sherwood, Neeley and Jones, London 1817
   Google Scholar
• Pick A. Ueber eine eigenthumliche Schreibstorung, Mikrographie, in Folge cerebraler Erkrankung. Prag Medizinische Wochenschrift 1903; 28: 1–4
   Google Scholar
• Reiter R. J. Changes in circadian melatonin synthesis in the pineal gland of animals exposed to extremely low frequency electromagnetic radiation: A summary of observations and speculation On their implications. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 13–27
   Google Scholar
• Rozencwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandyk R. Tardive dyskinesia and the pineal gland. International Journal of Neuroscience 1988; 43: 111–114
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience 1992a; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience 1992b; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields in the treatment of Parkinson's disease with the “on-off” phenomenon. International Journal of Neuroscience 1992c; 66: 97–106
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Serotonin in involuntary movement disorders. International Journal of Neuroscience 1988; 42: 185–205
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. The relationship of the reticular system to the primary pathoetiology of Parkinson's disease. International Journal of Neuroscience 1988; 42: 297–300
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence neuroleptic-induced movement disorders in pinealectomized rats. International Journal of Neuroscience 1989; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Kay S. R. Melatonin secretion and the pathophysiology of Meige's disease (idiopathic orofacial dystonia). A hypothesis. Functional Neurology 1990; 5: 165–170
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. The effects of external picoTesla range magnetic fields on the EEG in Parkinson's disease. International Journal of Neuroscience, in press a
   Google Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picoTesla magnetic fields in Parkinson's disease. International Journal of Neuroscience, in press b
   Google Scholar
• Sandyk R., Iacono R. P. Enhancement of visuoperceptive functions by picoTesla range magnetic fields in patients with Parkinson's disease. International Journal of Neuroscience, in press
   Google Scholar
• Sandyk R., Awerbuch G., Kay S. R. Pineal gland calcification and tardive dyskinesia. Lancet 1990; 335: 1528
   PubMed Web of Science ®Google Scholar
• Sandyk R., Anninos P. A., Tsagas N., Derpapas K. Magnetic fields in the treatment of Parkinson's disease. International Journal of Neuroscience 1992; 63: 141–150
   PubMed Web of Science ®Google Scholar
• Seguela P., Geffard M., Chauveau J., Muyard J. P., Biziere K., Le Moal M. Selective increase of melatonin content in pineal gland and nucleus accumbens after peripheral injection of Des-Tyr1-gamma-endorphin in the rat. Neuroscience Letters 1982; 10: S442
   Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Siegfried J. Die parkinsonsche krankheit und ihre behandlung. Springer Verlag, Wien 1968; 106
   Google Scholar
• Smythe G. A., Lazarus L. Growth hormone regulation by melatonin and serotonin. Nature 1973; 244: 230–231
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974a; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974b; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Stoupel E., Keret R., Assa S., Kaufman H., Shimshoni M., Laron Z. Secretion of growth hormone, and corticosteroids during different levels of geomagnetic activity. Neuroendocrine Letters 1983; 5: 365–368
   Web of Science ®Google Scholar
• Vitte P. A., Harthe C., Lestage P., Claustrat B., Bobillier P. Plasma, CSF and brain distribution of C14-melatonin in rat: a biochemical and autoradiographic study. Journal of Pineal Research 1988; 5: 437–453
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric field effects on pineal melatonin rhythms. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus. Brain research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology 1983; 37: 41–47
   PubMed Web of Science ®Google Scholar